Cost-Utility Analysis of Certolizumab Pegol Plus Methotrexate for the Treatment of Moderate-To-Severe Active Rheumatoid Arthritis In Greece.
作者信息
Tzanetakos C, Maniadakis N, Kourlaba G, Tzioufas A, Goules A, Theodoratou T, Christou P
机构信息
National School of Public Health, Athens, Greece.
Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece.
出版信息
Value Health. 2014 Nov;17(7):A382. doi: 10.1016/j.jval.2014.08.2624. Epub 2014 Oct 26.
PMID:27200853
Abstract
摘要
Zotero 插件